Elicio Therapeutics, Inc. financial statements
Elicio Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 39.57M | 10-K |
| Cash and equivalents | USD 18.56M | 10-Q |
| Total debt | USD 10M | 10-K |
Elicio Therapeutics, Inc. financials on 6ix · Elicio Therapeutics, Inc. on 6ix